FNCH
Finch Therapeutics Group Inc
$2.25
Earnings Summary
Revenue | $0Mn |
Net Profits | $-3.04Mn |
Net Profit Margins | -Inf% |
Highlights
Finch Therapeutics Group Inc’s revenue fell -100% since last year same period to $0Mn in the Q4 2023. On a quarterly growth basis, Finch Therapeutics Group Inc has generated NaN% jump in its revenue since last 3-months.
Finch Therapeutics Group Inc’s net profit jumped 88.45% since last year same period to $-3.04Mn in the Q4 2023. On a quarterly growth basis, Finch Therapeutics Group Inc has generated -25.87% fall in its net profits since last 3-months.
Finch Therapeutics Group Inc’s net profit margin fell -Inf% since last year same period to -Inf% in the Q4 2023. On a quarterly growth basis, Finch Therapeutics Group Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Finch Therapeutics Group Inc post its latest quarter earnings
EPS Estimate Current Quarter | -4.5 |
EPS Estimate Current Year | -4.5 |
Highlights
Finch Therapeutics Group Inc’s earning per share (EPS) estimates for the current quarter stand at -4.5 - a -4900% fall from last quarter’s estimates.
Finch Therapeutics Group Inc’s earning per share (EPS) estimates for the current year stand at -4.5.
Key Ratios
Key ratios of the Finch Therapeutics Group Inc post its Q4 2023 earnings
Earning Per Share (EPS) | -1.89 |
Highlights
Finch Therapeutics Group Inc’s earning per share (EPS) fell -238.18% since last year same period to -1.89 in the Q4 2023. This indicates that the Finch Therapeutics Group Inc has generated -238.18% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-05-10 | -0.09 | -0.38 | -322.22% |
2023-08-10 | -4.5 | -3.24 | 28% |
₹0 US Stocks a/c Opening Fee